FDA approves contrast agent for CNS MRI scans
The U.S. Food and Drug Administration has approved Gadavist (gadobutrol), a contrast agent for use in patients undergoing magnetic resonance…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.